ANCA: Serology in Wegener's granulomatosis

Indian Journal of Medical Sciences

Volumn 59, Issue 7, 2005, Pages 292-300

  Pradhan, V D ^a,b   Badakere, S S ^a   Ghosh, K ^a   Almeida, A ^b  

^a NATIONAL INSTITUTE OF IMMUNOHAEMATOLOGY   (India)

^b KEM HOSPITAL   (India)

Author keywords

Anti neutrophil cytoplasmic antibodies; Anti Proteinase3; Cytoplasmic ANCA; Enzyme linked immunosorbent assay; Indirect immunofluorescence; Wegener's granulomatosis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYTOPLASMIC NEUTROPHIL CYTOPLASMIC ANTIBODY; ENZYME ANTIBODY; HEMOGLOBIN; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PERINUCLEAR NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE 3 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE; KIDNEY; LEUKOCYTE COUNT; LOWER RESPIRATORY TRACT; MALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; UPPER RESPIRATORY TRACT; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 23344432785     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.16504     Document Type: Article

References (34)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL. et al. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. Wegener F. Wegener's granulomatosis. Eur Arch Otorhinolaryngol 1990;247:133-42.
3. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's Granulomatosis: Prospective clinical and therapeutic experience with 85 patients over 21 years. Ann Intern Med 1983; 98:76-85.
4. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA. et al. Autoantibodies against neutrophils and monocytes: A new tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-29.
5. Csernok E, Muller A, Gross WL. Immunopathology of ANCA-associated vasculitis. Intern Med 1999;38:759-65.
6. Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross W et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection: A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 1993;159:1-16.
7. Badakere SS, Pradhan VD. ANCA: Anti-neutrophil cytoplasmic antibodies and their role in vasculitis associated kidney disorders. Indian J Med Sci 2002;56:335-39.
8. Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL. Wegener's autoantigen decoded. Nature 1990;346:520.
9. Schultz DR, Diego JM. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies and report of a novel De novo ANCA associated vasculitis after kidney transplantation. Semin in Arthritis Rheum 2000;29:267-85.
10. Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG. et al. Prediction of relapses in Wegener's granulomatosis by measurement of anti-neutrophil cytoplasmic antibody test levels: A prospective study. Arthritis Rheum 2000;49:2025-33.
11. Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL. Serial ANCA titers: useful tool for prevention of relapses in ANCA- associated vasculitis. Kidney Int 2003; 63:1079-85.
12. Leavitt RY, Fausi AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
13. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P. et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87:671-8.
14. Rasmussen N, Sjolin C, Isaksson B, Bygren P, Wieslander J. An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA) J Immunol Methods 1990;127:139-45.
15. Jennings JG, Chang L, Savige JA. Anti-Protienase3 antibodies,: their characterization and disease associations. Clin Exp Immunol 1994;95:251-6.
16. Chikazawa H, Nishiya K, Matsumori A, Hashimoto K. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases. J Clin Immunol 2000;20:279-86.
17. Badakere SS, Chablani AT, Bhatia HM. Anti-nuclear factor in some autoimmune disorders. Proc. Recent Trends in Immunohaematol 1982:101-8.
18. Badakere SS, Chablani AT. Immunofluorescent techniques in immunohaematology. Immunohaemat Bull 1985;16:1-3.
19. Hatfield M, Evans M, Suenaga R, Hassanein KM, Abdou NI. Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids. Clin Exp Immunol 1987;70:26-34.
20. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: Immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993;91:1-12.
21. Luqmani RA, Bacon PA, Beaman M, Scott DG, Emery P, Lee SJ. et al. Classical versus non-renal Wegener's granulomatosis. Q J Med 1994; 87:161-7.
22. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Anti-neutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000;57:846-62.
23. Singh YN, Malaviya AN, Sharma SK, Kumar A, Wali JP, Dash SC. et al. Wegener's granulomatosis in Northern India. J Assoc Physicians India 1992;40:594-6.
24. Bambery P, Sakhuja V, Bhusnurmath SR, Jindal SK, Deodhar SD, Chaugh KS. et al. Wegener's granulomatosis: clinical experience with eighteen patients. J Assoc Physicians India 1992;40:597-600.
25. Kumar A, Pandhi A, Menon A, Sharma SK, Pande JN, Malaviya AN. Wegener's granulomatosis in India: Clinical features, treatment and outcome of twenty five patients. The Indian Journal of Chest Diseases & Allied Sciences 2001;43:1-7.
26. Kaushal R, Dash SC, Kapur S, Bhuyan UN. Wegener's granulomatosis with rapidly progressive glomerulonephritis. J Assoc Physicians India 1987; 35:382-4.
27. Dolman KM, Stegeman CA, van de Wiel BA, Hack CE, van dem Borne AE, Kallenberg CG. et al. Relevance of classic anti-neutrophil cytoplasmic antibody (C-ANCA)- mediated inhibition of proteinase3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol 1993;93:405-10.
28. Hagen EC, Daha M, Hermans J, Andrassy K, Csernok E, Gaskin G. et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-53.
29. Edgar JD, McMillan SA, Bruce IN, Conlan SK. An audit of ANCA in routine clinical practice. Postgrad Med J 1995;71:605-12.
30. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS. et al. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. Adv Exp Med Biol 1993; 336: 411-4.
31. Haubitz M, Koch KM, Brunkhorst R. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis. Nephrol Dial Transplant 1998; 13:1713-8.
32. Ludemann G, Gross WL. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol 1987; 69:350-7.
33. Pradhan VD, Badakere SS, Iyer YS, Kumar R, Almeida AF. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders. J Postgrad Med 2003; 49:5-10.
34. Schonermarck U, Lamprecht P, Csernok E, Gross WL. Prevalence and spectrum of rheumatic diseases associated with protienase3- antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology 2001; 40:178-84.